Peer adoption and development of health innovations by patients: national representative study of 6204 citizens by Oliveira, Pedro et al.
Original Paper
Peer Adoption and Development of Health Innovations by Patients:
National Representative Study of 6204 Citizens
Pedro Oliveira1,2, PhD; Leid Zejnilovic3, PhD; Salomé Azevedo2, MSc; Ana Maria Rodrigues4,5,6, MD, PhD; Helena
Canhão4,5,7, MD, PhD
1Copenhagen Business School, Copenhagen, Denmark
2Católica-Lisbon School of Business and Economics, Lisbon, Portugal
3Nova School of Business and Economics, Nova University, Lisbon, Portugal
4CEDOC, EpiDoC Unit, Nova Medical School, Nova University, Lisbon, Portugal
5Associação EpiSaúde, Évora, Portugal
6Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal




Department of Strategy and Innovation






Background: There is growing evidence that many patients and caregivers innovate by developing new solutions to cope with
their health disorders. Given the easy access to vast internet resources and peers globally, it is increasingly important to understand
what may influence user innovation and its adoption in health for improving individual well-being and ensuring their safety, in
particular, how interactions with peers and physicians or search behavior, along with sociodemographics, may influence the
decision to develop a solution or adopt one developed by a peer.
Objective: The aim of this paper was to study the development and peer-to-peer adoption of user innovations in health care
and identify individual-level factors associated with these processes.
Methods: Data were collected via computer-assisted phone survey from a large, random, and representative sample of adult
residents in Portugal (N=6204). User innovation questions were added to 1 wave of an ongoing observational, longitudinal,
population-based epidemiological study. By asking about individual innovation activity, the sample was split into 3 groups: (1)
the developers of health-related solutions for own use (developers), (2) the adopters of solutions developed by other patients or
caregivers (peer-to-peer adopters), and (3) the rest of the population. Within the last group, intention to adopt was measured and
used as a proxy of future behavior. Regression analysis is used to test the associations.
Results: In the population considered in this paper, an estimated 1.3% (75/6008) reported having developed a solution for own
use and 3.3% reported to have adopted a solution developed by peers. The 3 groups (developers, adopters, and remaining
population) have distinctive characteristics. Gender plays an important role in the solution development, as women are less likely
to develop one (odds ratio [OR] 0.4, 95% CI 0.20-0.81; P<.05). Education is positively associated with the development activity
(OR 1.13, 95% CI 1.03-1.24; P<.05) but also with the intentions to adopt a peer-developed solution. Search for health-related
information is positively associated with the development, adoption, and the intentions to adopt a solution. Interactions with peers
over the internet are rare, but in-person interactions are frequent and have a positive association with the dependent variables in
all 3 groups. The results also suggest that trust in doctors represents an important dimension that shapes the attitudes of the
population toward peer-developed solutions.
Conclusions: This paper demonstrates the importance of the peer community, doctor-patient relationship, citizen’s search for
information on innovation, and individual attitudes toward peer-to-peer adoption in health care. It stresses the need for a reliable
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Web-based health-related information and the necessity to deeper understand complex relationships between the need to improve
health and fulfill the need and the perception of the health care system.
(J Med Internet Res 2019;21(3):e11726)  doi: 10.2196/11726
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User innovators are the ones who have developed a new good
or service or modified an existing good or service for own use;
they differ from producer innovators for whom profit is the
dominant motivation to innovate [1]. Innovation scholars have
demonstrated the existence of this empirical phenomenon in
numerous industries, including health care [2]. Survey evidence
from measurement studies of user innovation at a national level
estimated that up to 0.5% of citizens in the United States, Japan,
Finland, and the United Kingdom modify or create new products
and services for personal health care–related use [3,4].
The largest group of user innovators in health care are patient
innovators, patients or their nonprofessional caregivers (eg,
parents and family members), who modify or develop a
treatment, a technical aid product, or a medical device to cope
with a health condition [5]. Besides developing, they may also
share or adopt solutions developed by other peers, they organize
themselves in communities, and either individually and or jointly
solve problems, and even do limited trials with solutions they
develop [6-9]. A study conducted in a population of rare disease
patients and their nonprofessional caregivers showed that the
frequency of user innovation might be higher among those
afflicted with rare diseases than in the general population. The
authors reported that 36% of interviewed survey respondents
had developed a solution that was new to them, and 8% of the
interviewed survey respondents had developed solutions that
may be novel to the medical practice [6].
When the value of patient-developed solutions is considered,
there is evidence of patients reporting significant improvements
in the quality of life after using their self-developed solutions
[6]. Furthermore, the study by Oliveira and Canhão [10]
identified successful cases of novel patient-developed solutions
that made a significant impact on medical practice. Health
benefits and social value of innovations can only be achieved
when innovations diffuse—when they are adopted and used by
other people. In national-level surveys, the fraction of diffused
user innovations observed varied from 5% to 17%, with the
most common diffusion pathway being peer-to-peer exchange
[3,4,11]. In the rare disease study, 32% of solutions reported
by the patients and caregivers were shared with others—almost
double the highest diffusion incidence observed in the general
population—but only 5% shared the information with their
doctor [6]. The existing evidence strongly suggests that the
innovation and diffusion activity by patient innovators is
significant but mostly hidden from the traditional health care
system. The adoption side of the peer-to-peer innovations in
health has received little or no attention from academia.
Rational and Aim
Innovation and adoption activity by patients and caregivers in
health care may be strongly influenced by health care–related
and sociotechnological contextual factors. However, no prior
work systematically explored such relationships. For example,
we know that people invest significant efforts to search for
health-related information (online and offline) [12] and may
have well-developed strategies for evaluating the credibility of
the information [13]. However, we do not know the relationship
of such a search with the innovation or peer-to-peer adoption
activity. Other sociotechnical and health care contextual factors
of interest may also include characteristics of the peer networks
among patients [14,15], doctor-patient relationships [15-17],
personal responsibility for health, or the trust in the availability
of scientific breakthroughs for their health disorder. This work
is, to the best of our knowledge, the first to systematically
explore the relationships between these contextual factors and




The data used in this paper are survey responses from a random
and representative sample of adult residents in Portugal
(N=6204), collected via computer-assisted phone survey
conducted by NOVA Medical School. Professional interviewers
were additionally trained by a psychologist to communicate the
innovation questions, and 2 of the authors trained them to fill
in the survey responses in a computer program during the
conversation.
The innovation section of the survey, which is the focus of this
paper, was integrated into a larger project, the second wave of
a longitudinal, prospective, observational, population-based
study named Epidemiology of Chronic Diseases (EpiDoC)
(Figure 1) [18]. The first wave, entitled EpiDoC 1 Epidemiology
of Rheumatic Diseases Study (EpiReumaPt), was rigorously
designed to gather a representative random sample of residents
in Portugal. In this phase, data were collected by face-to-face
interviews of 10,661 individuals in the period from 2011 to
2013 [19]. Inclusion criteria were as follows: (1) Portuguese
speaking individuals, (2) aged 18 years or older, (3)
noninstitutionalized (excluding hospital or nursing homes,
military barracks, and prisons), (4) for whom cognitive and
physical impairments did not prevent completion of the survey,
and (5) who were living in a private household in the country.
Participants were selected through a process of multistage
random sampling. The sample was stratified according to the
Portuguese statistic regions in the 2001 Census and the size of
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the population (<2000; 2000-9999; 10,000-19,999;
20,000-99,999; and ≥100,000 inhabitants). The number of
participants of each stratum was proportional to the actual
distribution of the population. In Madeira and the Azores, the
sample size was increased (oversampling) to allow separate
analyses in these regions. Candidate households were selected
through a random route process; sampling points were randomly
selected on the maps of each locality, where the interviewer
began a systematic step count (defined for each locality
according to its size), granting each household and everyone an
equal probability of being chosen [19].
Most of the EpiDoc wave participants (10,153) also agreed to
integrate into a prospective cohort and be contacted in the next
round of surveying (EpiDoc 2)—the cohort of rheumatic
diseases (CoReumaPt) wave (2013-2015). The Portuguese
National Commission for Data Protection and the NOVA
Medical School Ethics Committee have approved both
EpiReumaPt and CoReumaPt [19]. The participants provided
informed consent to participate in all phases of the study, and
the study was conducted in accordance with the Declaration of
Helsinki. Professional interviewers conducted all the interviews.
In EpiDoC 2 (CoReumaPt), the follow-up phase, 7591 (out of
10,153) individuals completed a computer-assisted telephone
survey. Of these, 6204 individuals were asked for and answered
the innovation activity part of the survey. The questions about
innovation activity were introduced 2 months after the launch
of the follow-up study, which explains the difference in the
number of respondents for this paper.
To guarantee the representativeness of the sample in relation to
the Portuguese population (Mainland and Madeira and Azores
islands), extrapolation weights were computed and used in
statistical analysis. The weights were obtained by calibrating
the extrapolation weights originally designed for the EpiDoC
1 (EpiReumaPt) sample. Participants and nonparticipants of the
EpiDoC 2 (CoReumaPt) study were compared regarding their
sociodemographic, socioeconomic, and health status
characteristics. Weights were then adjusted based on this
comparison and the stratification by statistical regions in
Portugal, sex, and age groups [18].
Figure 1. Flowchart of the population-based study named Epidemiology of Chronic Diseases (EpiDoC). The first wave (2011-2013) is entitled EpiDoC
1 - Epidemiology of rheumatic diseases study (EpiReumaPt). The second wage (2013-2015) is entitled EpiDoc 2 - Cohort of rheumatic diseases
(CoReumaPt).
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0.9“It is me, more than any other person, who is responsible for my health and
well-being.” (5-point Likert scale: 1=totally disagree, 5=totally agree)
Self-responsibility for health (2 items, adapted from
a scale by Hibbard et al [22])
0.9“The most important factor that influences my well-being and health is my
active role and responsibility for my health.” (5-point Likert scale: 1=totally
disagree, 5=totally agree)
Self-responsibility for health (2 items, adapted from
a scale by Hibbard et al [22])
0.9“I trust my doctor so much that I always try to follow his/her advice.” (5-point
Likert scale: 1=totally disagree, 5=totally agree)
Trust in medical doctor (Reduced scale proposed
by Anderson et al [23])
0.9“If my doctor tells me something is so, then it must be true.” (5-point Likert
scale: 1=totally disagree, 5=totally agree)
Trust in medical doctor (Reduced scale proposed
by Anderson et al [23])
0.8“I feel my doctor does everything he/she should for my medical care.” (5-point
Likert scale: 1=totally disagree, 5=totally agree)
Trust in medical doctor (Reduced scale proposed
by Anderson et al [23])
0.9Do you believe that the medical science can treat your disease? (5-point Likert
scale: 1=not at all, 5=completely trust)
Perceptions of medical science frontiers (new)
0.9How likely is it that the medical science can successfully treat you for your
disease? (5-point Likert scale: 1=not at all, 5=it certainly can)
Perceptions of medical science frontiers (new)
0.9How likely is it that you would use a solution developed by another patient to
help you cope with your ailment? (5-point Likert scale: 1=very unlikely, 5=I
would definitely)
Intention to adopt a patient-developed solution [20]
0.9Do you intend to use a solution developed by another patient to help you cope
with your ailment? (5-point Likert scale: 1=I do not intend to use, 5=I definitely
intend to use one)
Intention to adopt a patient-developed solution [20]
Survey Flow and 3 Groups of the Respondents
The first group of questions in the innovation section of the
survey measured contextual factors, self-responsibility for health
management, search for health information, the frequency of
online and face-to-face interactions with peers, and trust in
medical doctors and medical science. Next, respondents
answered a question that split the sample into 3 groups: (1) the
developers of solutions to cope with their health disorders, (2)
adopters of health-related solutions developed by other patients
or caregivers, and (3) the remaining population.
The question asked if an individual had developed a
health-related solution or adopted a health-related solution
developed by other patients. In the case of an affirmative
response, the survey continued with sections that focused on
the details about solution development or adoption, dividing
the population into the developer or adopter groups. The third
group, those who neither innovated nor adopted a solution, were
asked whether they have ideas about potential solutions for
health-related problems they so far encountered. Those who
neither developed nor adopted a patient-developed solution
were also asked about their intentions to adopt a
patient-developed solution. For all the respondents, the survey
started with sociodemographic questions and ended with life
habits, functional, and quality of life questionnaires.
Creative Activity: Solution Development or Adoption of
a Patient-Developed Solution
Questions regarding user innovation were built upon a
questionnaire used in user innovation measurement surveys [3],
adapting it to the health care context. As the conversation was
phone-based, the calling party explicitly introduced the purpose
of the innovation-related questions. The interviewers asked the
respondents if they had, in their free time, done anything that
would help them or someone close to them to cope with their
health disorders. To ease the interpretation, we provided mental
cues of what the potential solutions may be. The cues suggested
to the respondents were medical aid instrument, medical
dispositive, behavioral strategy (eg, a diet or an exercise plan),
tools for everyday life at home or work, solutions related to
one’s appearance, medication or a combination of drugs, and
natural products.
The question about creative activity is formulated to ask about
newly developed or modified solutions and about the adoption
of a patient-developed solution for personal use or for someone
close to the respondent. From the survey responses on this
question, 2 dependent (binary) variables were created, a solution
development variable (developer) and a solution adoption
variable (adopter). Furthermore, the origin of the advice for the
adopter was asked for, to ensure that the source of the solution
is a patient/caregiver. The objective was to identify the
characteristics of those who had engaged in creative activity,
regardless of the artifact’s quality that is developed or adopted.
A large share of the population is likely to be neither solution
developers nor adopters of peer-developed solutions, as not
everyone has a need for a solution to cope with health-related
issues. For this group, and to study the drivers of the attitude
toward peer-developed solutions in a general population, the
theory of planned behavior [20] is used. According to the theory,
intentions are a relatively good proxy of future behaviors [21].
The behavioral intentions to adopt a patient-developed solution
in this paper are measured using a 2-item scale (Table 1). Note
that because of the survey complexity, the groups are exclusive,
which means that the developers were neither asked if they had
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also adopted nor about their intentions to adopt a solution.
Furthermore, the adopters were not asked about their intentions
to adopt a solution.
Health Care Contextual Factors
Considering the earlier stated goal of this paper, learning about
individual creative activity in the health care context, a set of
questions was added to the survey. To learn about individual
search efforts, the survey measured the depth of search for health
information and health-related solutions as the average weekly
time spent searching. As social interactions among patients may
influence adoption or intentions to adopt a patient-developed
solution, the interviewees were asked about the frequency of
their interactions with individuals who are afflicted with the
same health disorder or who share interests in the disorder;
5-point Likert scales were used to represent different levels of
frequency of interactions.
To measure the perceptions of the scientific frontier, trust in
medical doctors, and the attitude toward personal health
management, where possible, existing scales were used (reported
in Table 1).
The medical part of the survey, pertinent to the epidemiological
study, included standard measurement instruments that assessed
health and quality of life. In this paper, the EuroQoL-5D
(EQ-5D) score [24] was used, as it is a validated, reliable, and
short standard health state instrument that suits the context well.
As we had 2 measures of EQ-5D score, 1 from EpiReumaPt
(2011-2013) and the other from CoReumaPt (2013-2015), a
variable that represents the difference between the 2 EQ-5D
scores has been generated. Note that this variable is used only
in the context of future activities and is included only in the
model that predicts the intentions to adopt a solution. To assess
who is afflicted with a health disorder, a binary variable is
generated from self-reported data, indicating which individual
has a clinically diagnosed chronic noncommunicable disease.
The list included the following groups of diseases/health
disorders: diabetes, pulmonary disease, cardiac disease,
gastrointestinal disease, neurologic disease, mental disease,
neoplastic disease, thyroid and parathyroid disease, and
rheumatic disease. A person is considered ill if there was a report
of having at least one disorder from the list (Multimedia
Appendix 1).
Statistical Analysis
Given that measurement instruments were used, the survey was
pretested on 106 randomly selected interviewees. In this step,
exploratory factor analysis is conducted to test whether
theoretically constructed 4 factors could be identified and if
there is a sufficient level of internal consistency.
Descriptive statistics are reported for the full sample (N=6204)
after applying probability weights to obtain the population
estimates [19,25]. Statistical software, StataCorp. 2017. Stata
Statistical Software: Release 15. College Station, TX: StataCorp
LLC, was used to conduct multivariate regression on survey
data with the probability weights. The objective of the analysis
is to explore the existence of statistically significant associations
between the outcomes and independent variables. A total of 3
sets of analysis are conducted for the 3 groups. For the first 2
groups, developers and adopters, logistic regression is used to
study the group differences. For the third group, the ones who
neither developed nor adopted a peer-developed solution, the
sample was divided in 2 subpopulations: (1) patients with at
least one chronic noncommunicable disease and (2) healthy
population. For both subsamples, ordinary least square models
were used to explore the associations of the independent
variables with the intentions to adopt. In all models, the
threshold of statistical significance is set to P<.05.
The scales for self-responsibility for health, trust in doctors,
and perceptions of medical science frontiers are included as
standardized values, and the interpretation of the coefficients
should be in terms of the SDs from the population mean.
Results
Sociodemographic Characteristics, Health Status, and
Peer Interactions
The results of exploratory factor analysis on the initial sample
of 106 individuals suggest that the items load well on the 4
factors, and all the factors have high internal consistency
(alpha≥.7) [22]. In Table 1, factor loadings are reported for the
entire sample.
Descriptive statistics are reported in Table 2 for the 3 groups
(developers, adopters, and remaining population). In total, 6008
responses were included after removing responses of the
individuals who could not answer the creative activity–related
question. For categorical variables, the absolute count is
provided, together with population estimates percentages in the
brackets. For continuous variables, means and SDs are
population estimates.
The results show that 1.3% of the population reported being
developers and 3.3% peer-to-peer adopters. The respondents
have on average 9 years of formal education (SD 4 years), and
49% reported being diagnosed with at least one
noncommunicable chronic disease.
There are notable differences among the 3 groups along several
dimensions. Within the developers’ group, males represent the
majority (66%). Furthermore, unemployment or temporal
disability/retirement among the developers (54%) is higher than
that among adopters (39%) or the remaining population (35%).
The developers have, on average, 1 more year of education than
the adopters. For all 3 groups, interacting with peers
(patients/caregivers) via the internet is rare, and the remaining
population (neither developers nor adopters) are more active in
that regard, with 2% more active people than that in the other
2 groups. Majority of the developers and adopters have frequent
in-person interactions, 65% and 53%, respectively. The adopters
have a higher number of comorbidities, 2.1 compared with 1.9
for developers and 1.5 for the rest of the population, on average.
Although all 3 groups have left-skewed self-responsibility for
health (4.9 out of 5), developers are more active than others, as
64% exercise regularly compared with around 40% in the other
2 groups. All 3 groups have high trust in doctors, with a
marginally higher value for the remaining population, 4.5
compared with 4.3 out of 5. Perception of medical science
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frontier is also left-skewed, with average values of 3.5 for the
adopters and 3.8 for the other 2 groups.
Absolute values of correlations between independent variables
(correlation matrix available upon request) were below .35, with
4 exceptions. These exceptions were (1) age and education
(r=−.6), (2) age and having at least one chronic disease (r=.41),
(3) having at least one chronic disease and the quality of life
score (r=−.38), and (4) quality of life score and education
(r=.38). However, at these values, the correlation listed above
are not considered problematic regarding multicollinearity.
Table 2. Descriptive statistics for the 3 groups (Innovator, Adopter, Remaining Population).
Remaining population
(n=5723)
Adopter (n=210)Innovator (n=75)Population characteristics
3146 (47.6)172 (58.4)40 (34.0)Gender (female), n (%)
46.41 (17.85)49.53 (17.09)44.62 (14.40)Age (years), mean (SD)
8.92 (3.81)8.33 (3.93)9.36 (3.28)Years of education, mean (SD)
Employment status, n (%)
3193 (65.2)116 (60.9)38 (45.8)Employed full-time, part-time, or domestic worker
1834 (24.9)70 (30)24 (22.4)Temporally work disabled/retired
479 (9.9)23 (9.1)8 (31.7)Unemployed
Portuguese Nomenclature of Territorial Units for Statistics, n (%)
1883 (37.8)65 (32.5)17 (33.1)Norte
1210 (23.7)49 (25.4)23 (36.4)Centro
1135 (24.3)46 (28.2)15 (17.2)Lisboa
264 (6.3)12 (7.4)5 (8.2)Alentejo
170 (3.6)4 (3)1 (2.2)Algarve
521 (2.0)17 (1.5)7 (1.4)Azores
540 (2.3)17 (2)7 (1.6)Madeira
2390 (44.6)85 (40.0)37 (63.9)Physical exercise at least once per week, n (%)
0.80 (0.26)0.73 (0.27)0.71 (0.23)Quality of life, EQ-5Da score—CoReumaPtb, mean (SD)
−0.05 (0.24)−0.09 (0.27)−0.05 (0.26)EQ-5D score difference CoReumaPtb-EpiReumaPtc, mean (SD)
1.51 (1.71)2.07 (2.55)1.81 (1.64)Number of chronic diseases, mean (SD)
Frequency of interaction with other patients or caregivers (face-to-face), n (%)
3181 (58.3)88 (48.8)30 (36.2)Never
1298 (22.3)61 (26.9)12 (10.1)Less than once a week
1207 (19.4)60 (24.3)33 (53.7)At least once a week
Interaction with other patients or caregivers (internet), n (%)
5450 (96.1)248 (92)69 (92)No
179 (3.9)16 (8)6 (8)Yes
0.47 (1.64)1.09 (2.08)1.97 (4.2)Depth of search: search time on health (hours per week), mean (SD)
4.86 (0.41)4.90 (0.30)4.82 (0.28)Self-responsibility for health, mean (SD)
4.47 (0.79)4.35 (0.86)4.31 (0.73)Trust in doctors scale, mean (SD)
2.63 (0.3)——dIntentions to adopt, mean (SD)
3.85 (0.94)3.53 (1.12)3.81 (0.85)Perceptions of medical science frontier, mean (SD)
aEQ-5D: EuroQoL-5D.
bCoReumaPt: Cohort of rheumatic diseases (EpiDoC 2).
cEpiReumaPt: Epidemiology of rheumatic diseases study (EpiDoC 1).
dNot applicable.
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Results of the Multivariable Analysis
Results of the multivariable analysis are shown in Table 3. A
total of 3 dependent variables (developer, adopter, and intentions
to adopt) correspond to the 3 groups of interest.
Developer
Considering the solution development for own use (model 1),
the results show that women are less likely to develop a solution
for own use (OR 0.40, 95% CI 0.20-0.81; P<.05). Education is
positively associated with the development activity (OR 1.13,
95% CI 1.03-1.24; P<.05), and the developers are more likely
to be unemployed than employed (OR 6.45, 95% CI 2.40-17.29;
P<.01). Considering health care contextual factors, the
developers are more likely to have face-to-face interactions with
other patients or caregivers (once a month or more) than no
interaction (OR 4.92, 95% CI 2.20-10.99; P<.01). Furthermore,
they are more likely to have at least one chronic,
noncommunicable disease (OR 2.85, 95% CI 1.30-6.27; P<.01)
and to search for health information more intensely than the
rest of the population (OR 1.15, 95% CI 1.04-1.26).
Adopter
The population of adopters is significantly different from the
population of developers. Adoption (model 2) is weakly
positively associated with female gender (OR 1.54, 95% CI
0.94-2.52; P<.10) and online interactions with other patients
(OR 2.12, 95% CI 0.95-4.74; P<.1). Adopters are, like
developers, more likely to invest time to search for health
information than the remaining population (OR 1.11, 95% CI
1.03-1.20; P<.01).
Remaining Population—Intentions to Adopt
In models 3 and 4, the dependent variable is the intention to
adopt a solution developed by a patient or a nonprofessional
caregiver. Intentions, according to the theory of planned
behavior, are a proxy for actual behavior. In this paper, they are
interpreted as attitudes toward peer-developed solutions.
The results for the subsample of individuals with at least one
chronic noncommunicable disease (model 3) suggest a distinct
combination of statistically significant associations. Intentions
to adopt are negatively associated with age (beta=−.01; 95% CI
−0.02 to −0.01; P<.01) and positively associated with education
(beta=.02; 95% CI 0.00-0.03; P<.05). Like developers and
adopters, in the remaining population, those with a chronic
disease with higher intentions to adopt are more likely to invest
their time to search for health-related information (beta=.07;
95% CI 0.02-0.13; P<.05) and more likely to have frequent
in-person interactions with other patients/caregivers. Unlike the
other 2 groups, developers and adopters, doctor-patient
relationship plays an important role; the lower the trust in doctor,
the higher is the intention to adopt a peer-developed solution
(beta=−.08; 95% CI −0.14 to −0.02; P<.01).
Within the remaining population, the subsample of individuals
without a chronic disease is very similar to the subsample of
those with a chronic disease. Distinctive characteristic of the
former subgroup is a negative association between
retirement/temporary work disability and the intentions to adopt
a peer-developed solution (beta=−.23; 95% CI −0.41 to −0.04;
P<.05; model 4).
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Table 3. Multivariable analysis with population estimates.
Intentions to adopt (remain-
ing population without a
chronic disease); Model 4,
beta estimates (95% CI)
Intentions to adopt (remain-
ing population with a chron-
ic disease); Model 3, beta
estimates (95% CI)
Adopter (versus all
the others); Model 2,
odds ratio (95% CI)
Developer (versus all
the others); Model 1,
odds ratio (95% CI)
Population characteristics
0.01 (−0.10 to 0.12)− .12a (−0.23 to −0.00)1.54b (0.94 to 2.52)0.40a (0.20 to 0.81)Gender: female versus male
− 0.01c (−0.01 to −0.00)− .01c (−0.02 to −0.01)1.00 (0.99 to 1.02)0.99 (0.96 to 1.02)Age (years)
0.03c (0.01 to 0.04).02a (0.00 to 0.03)0.95 (0.87 to 1.03)1.13a (1.03 to 1.24)Education (in years)
− 0.23a (−0.41 to −0.04)−.02 (−0.16 to 0.13)0.95 (0.53 to 1.72)1.41 (0.53 to 3.79)Employment: temporarily work dis-
abled/retired versus employed (full- or
part-time)
−0.14 (−0.34 to 0.06).04 (−0.13 to 0.21)1.02 (0.55 to 1.90)6.45c (2.40 to 17.29)Employment: unemployed versus em-
ployed (full- or part-time)
−0.02 (−0.14 to 0.09)−.00 (−0.13 to 0.12)1.20 (0.66 to 2.19)2.46b (0.98 to 6.14)Marital status (married or union versus
single or widow or divorced)
0.03 (−0.08 to 0.14).08 (−0.06 to 0.21)0.85 (0.52 to 1.38)1.87a (1.03 to 3.40)Regular physical exercise
−0.23 (−0.61 to 0.15)−.02 (−0.26 to 0.23)1.09 (0.30 to 4.03)0.63 (0.25 to 1.62)Health state, EQ-5Dd score—CoReumaPte
−0.03 (−0.37 to 0.32)−.09 (−0.31 to 0.14)——gScore Difference EQ-5D score:
CoReumaPte-EpiReumaPtf
—.27c (0.13 to 0.40)1.24 (0.74 to 2.08)0.68 (0.27 to 1.71)Face-to-face Interaction with other pa-
tients/caregivers: less than once a month
versus no interactions
—.27c (0.13 to 0.42)1.21 (0.72 to 2.02)4.92c (2.20 to 10.99)F2F Interaction with other patients/care-
givers: once a month or more versus no
interactions
—−.09 (−0.38 to 0.19)2.12b (0.95 to 4.74)0.62 (0.12 to 3.14)Online interactions with other patients
−0.00 (−0.04 to 0.04).07a (0.02 to 0.13)1.11c (1.03 to 1.20)1.15c (1.04 to 1.26)Health information search depth (hours
per week)
0.04 (−0.04 to 0.11)−.04b (−0.09 to 0.00)1.14 (0.90 to 1.44)1.06 (0.73 to 1.56)Personal responsibility for health (standard-
ized)
− 0.14c (−0.19 to −0.09)− .08c (−0.14 to −0.02)0.94 (0.80 to 1.09)0.92 (0.72 to 1.18)Trust in physician (standardized)
−0.02 (−0.08 to 0.04)−.01 (−0.07 to 0.04)0.81 (0.63 to 1.05)0.99 (0.71 to 1.37)Perceptions of medical science frontier
(standardized)





eCoReumaPt - Cohort of rheumatic diseases (EpiDoC 2).




The analysis suggests that solution development and adoption
of peer-developed solutions are relatively infrequent but
significant phenomena and that the 3 groups have distinctive
characteristics. Population estimates of the share of solution
developers, 1.3%, is over 2 times higher than the estimate of
the share of health care–related innovation by citizens in the
United Kingdom [4]. As there was no restriction on the novelty
of the reported solutions, as it could not be established, the
reported estimates in this paper are regarding solution developers
and not user innovators. In other words, the comparison is not
applicable. Regarding the population estimates of the adopters,
this is the first time for such an estimate to be taken.
A series of results are aligned with the extant academic literature
in user innovation. Regression results suggest that solution
developers are more often men and educated individuals,
confirming the findings from the study of user innovations by
J Med Internet Res 2019 | vol. 21 | iss. 3 | e11726 | p. 8http://www.jmir.org/2019/3/e11726/
(page number not for citation purposes)
Oliveira et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
consumers in the United Kingdom [4]. Furthermore, our paper
showed that active interactions with peers are positively
associated with solution development, which corroborates the
findings of Hienerth and Lettl [26] who studied the influence
of peer communities on user innovation. From a public policy
perspective, if the goal is to stimulate solution development by
patients and caregivers in health care, a meaningful investment
could be in the development of communities of peers. An
example of a successful investment is the Enabling the Future
community where patients, caregivers, and community members
come together to develop open-source models of
3-dimensional-printed hands [7]. Albeit, integrating knowledge
and experience of users to improve health care is complex, and
the effects often fail short of the expectations [27]. Although
intuition may suggest internet as a great platform for
communities, the results of this paper suggest that most of the
respondents, developers, adopters, and even ill people from the
remaining population who have higher intentions to adopt a
peer-developed solution prefer in-person interactions among
peers over contacts through the internet.
Our study showed that developers are more likely to be
unemployed than employed. A plausible explanation may be
that they have more time to reflect upon needs and solutions or
that unemployment is associated to a higher likelihood of
suffering from health disorders and to having financial
difficulties [23], which implies the higher need to solve
problems.
Group-mean comparison suggests that the average time spent
searching for health-related information by the developers (2
hours/week) is almost twice the time spent by the adopters (1.1
hours/week) and 4 times higher than that for the rest of the
population (0.5 hours/week). This result emphasizes the
importance of the provision of curated and accurate information,
especially when, following an advice of a peer without
consulting a health professional may be quite dangerous. For
example, applying a plant extract without understanding side
effects or permitted dosages may provoke serious health issues.
Considering adoption of solutions developed by patients or
caregivers, the regression results do not suggest any stark
characteristic of the group of adopters. However, the application
of the intentions to adopt, a concept from the theory of planned
behavior, reveals an important association. The attitude of those
who did not engage in neither developing a solution nor adopting
one may be influenced by the doctor-patient relationship. In
light of the safety concerns regarding the diffusion of
(self-made) health solutions in informal communities of patients
and caregivers, doctors are a vital element of the health care
system that helps patients to establish safety and efficacy of the
available solutions. A negative association between the
intentions to adopt and age possibly reflects the generational
change in the perception of the role of the conventional health
care system. In particular, older individuals may be used to the
paternalistic doctor-patient relationship, and they may put a
higher value on the official source of health-related solutions.
Education is positively associated with the intentions to adopt
a solution, which is also potentially linked to the paradigm shift
in health care from paternalistic to more egalitarian relationships
between patients and health professionals.
Limitations, Strengths, and Further Research
In this paper, data have been collected from a prospective cohort;
as we worked with cross-sectional data, only associations may
be claimed. Recollection and interpretation bias may be present
in the data. Although some people may have developed or
adopted a patient-developed solution without being aware of it,
the focus of this work was to explore the characteristics of those
who are aware and have had chosen to develop or adopt a
peer-developed solution. Hence, these biases are likely not to
influence the results significantly.
A set of preemptive steps were taken before administering the
survey to control for item-related (common method) bias, as
suggested by Podsakoff et al [28]. These measures include ease
of cognitive load on the individuals and the design of the
questions and their order to avoid the item-related bias.
The advantage of the study is the size of the sample and the
sampling design. As this study is conducted in 1 country, it casts
doubt whether the results are generalizable to other cultural and
health care policy settings.
Conclusions
This paper is the first-of-type exploratory analysis of creative
activities in the general population that focuses on health care
and takes into consideration health care contextual factors. It
demonstrates distinctive characteristics of: (1) the patients and
caregivers who are developers of solutions, (2) the adopters of
peer-developed solutions, and (3) the attitudes of the remaining
population. Two actionable takeaways from the study are the
importance of supplying reliable health-related information to
patients who are searching and of the investment in good
doctor-patient relationships.
Treating patients as equals is becoming the new mantra in
organized health care systems [29], and we need to consider
carefully what it means regarding their creative work, knowledge
contribution, and organization and delivery of medical care.
Only when we understand and support the creative contributions
of the patients, we will have a system that truly integrates them.
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